Better imaging for liver tumors using PET/MRI
Part of Cancer, Digestive system clinical trials.
This study tests whether a combined PET/MRI scan can better find and see liver tumors or cancer that has spread to the liver. If you are eligible, you will get this special imaging test, which may help doctors diagnose and plan your treatment more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have or are suspected to have a liver tumor or liver metastases
- You are able to undergo a PET/MRI scan (which involves lying still in a scanner)
- You are willing to follow the study rules
- You have no allergy to MRI contrast dye, are not pregnant or breastfeeding, and do not have severe heart, kidney, or liver failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two advanced imaging tests — PET/CT and enhanced MRI — to see which one finds liver cancers or spread to the liver more accurately. If you join, you'll get one or both of these scans, which may help your doctor spot issues earlier and plan your care better.
This study looks at how well special imaging scans (PET/CT or PET/MRI) work in adults with suspected or diagnosed liver cancer. It may help doctors better see the cancer and plan next steps.
This trial studies how well a special imaging test (68Ga-FAPI PET/MRI) can detect and evaluate hepatocellular carcinoma (HCC), a type of liver cancer. It may help doctors confirm diagnosis and plan next steps by seeing how the cancer takes up the tracer.
This study compares different scan types (MRI, CT, and two PET scans) in people with hepatocellular carcinoma (a primary liver cancer). It may help doctors figure out which scan gives the most useful information for diagnosis and treatment planning.
This trial tests whether a new PET imaging agent (GPC3-targeted) can find liver cancer as well as or better than enhanced MRI. It may help diagnose hepatocellular carcinoma (the most common type of liver cancer) more accurately.
This study tests a new imaging tracer to better see liver cancer on PET scans, which might help doctors find or monitor tumors more accurately.
Hear when a new Liver Cancer, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.